Selective degradation of platelet BTK by PROTAC NX-5948 provides antithrombotic benefits without affecting haemostasis
Carl May, Justin S. Trory, Connor E. Webb, Hetty S. Walker, Yong Li, Jonathan Alan Furniss, Johannes A. Eble, Alastair W. Poole, Jordan Vautrinot, Jay Tromans, Ingeborg Hers
This paper shows that NX-5948, a BTK degrader, reduces thrombosis without affecting haemostasis by selectively degrading platelet BTK.
Blood Advances · Jun 30, 2026Peer-reviewedCell Biology